Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manufacturing NV, Belgium, Distributed by: Sandoz, Inc., Princeton, NJ, NDC# 0781-6186-67, Carton NDC# 0781-6186-67
Published September 17, 2025 · Recall initiated: August 13, 2025
Summary
FDA records drug Class II recall D-0626-2025, published September 17, 2025 and initiated August 13, 2025. Recalling firm: Sandoz Inc; Status: Ongoing; Reported quantity: 1,680 bottles; Lot: Lot # VNF35A, Exp.08/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Temperature Abuse
What to do
Voluntary: Firm initiated · Letter
Get an email if CIPROFLOXACIN AND DEXAMETHASONE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CIPROFLOXACIN AND DEXAMETHASONE
- Manufacturer
- Sandoz Inc
- Distributor
- Product was distributed to one consignee in CA.
- UPC
- 0307816186677
- Lot
- Lot # VNF35A, Exp.08/31/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 10 Tablets unit dose blister packSeptember 17, 2025
- FDANeuroquell & Neuroquell Plus, .22 fl. Oz (6.6mL),Mfg. For/Dist. By Claire Ellen Products, P.O. Box 901September 17, 2025
- FDASulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 100 Tablets unit dose blister packsSeptember 17, 2025
- FDAChlorpromazine Hydrochloride Tablets, USP, 10 mg, 100-count bottle, Rx only, Manufactured By: ZydusSeptember 17, 2025
- FDASuccinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile,September 17, 2025
- FDAChlorpromazine Hydrochloride Tablets, USP, 10 mg, 100-count bottle, Rx only, Manufactured By: ZydusSeptember 17, 2025
Questions about this recall
Was Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manufacturing NV, Belgium, Distributed by: Sandoz, Inc., Princeton, NJ, NDC# 0781-6186-67, Carton NDC# 0781-6186-67 recalled?
Yes. FDA published recall D-0626-2025 on September 17, 2025. Reported hazard: Temperature Abuse
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CIPROFLOXACIN AND DEXAMETHASONE. UPC: 0307816186677.